Analytical methods | ||
---|---|---|
Comparative study | #1 | |
Chromatography | LC | |
Ion source | ESI | |
Positive/Negative mode | positive | |
Mass analyzer | Q-TOF | |
Identification level | MS/MS |
Sample information | ||
---|---|---|
Comparative study | #1 | |
Country | China | |
Specimen | tissue | |
Marker function | diagnosis | |
Participants(Case) | Cancer type | adenocarcinoma |
Stage | I | |
Number | 25 | |
Gender (M,F) | – | |
Mean age (range) (M,F) | 46-82 | |
Smoking status | – | |
Participants(Control) | Type | tumor vs. adjacent normal tissue |
Number | 25.0 | |
Gender (M,F) | – | |
Mean age (range) (M,F) | 46-82 | |
Smoking status | – |
Data processing and metabolite identification | |
---|---|
Data processing software | Progenesis QI |
Database search | LIPID MAPS, HMDB |
Statistics and concentration information | |
---|---|
Differential analysis method | Student's t test |
Classification method | – |
Survival analysis method | – |
Metabolite | Comparative study | Author-emphasized biomarkers | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
---|---|---|---|---|---|---|---|---|
SM(42:2) | – | V | – | – | – | < 0.0001 | – | – |
PC(16:0/18:1) | – | – | – | – | – | 0.2879 | – | – |
PC(36:4) | – | – | – | – | – | 0.2545 | – | – |
PC(16:0/16:0) | – | V | – | – | – | 0.0432 | – | – |
Metabolite | Comparative study | Author-emphasized biomarkers | Cutoff value | AUROC (95%CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|---|---|
SM(42:2) | – | V | – | – | – | – | – |
PC(16:0/18:1) | – | – | – | – | – | – | – |
PC(36:4) | – | – | – | – | – | – | – |
PC(16:0/16:0) | – | V | – | – | – | – | – |